HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Woo Jeong Selected Research

cordycepin

3/2020Cordycepin Resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription.
10/2018Cordycepin inhibits lipopolysaccharide-induced cell migration and invasion in human colorectal carcinoma HCT-116 cells through down-regulation of prostaglandin E2 receptor EP4.
3/2015Cordyceptin induces apoptosis through repressing hTERT expression and inducing extranuclear export of hTERT.
9/2013Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway.
3/2013Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen species‑mediated mitochondrial death pathway.
5/2012Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt.
6/2011Induction of apoptosis by cordycepin via reactive oxygen species generation in human leukemia cells.
12/2010Anti-inflammatory effects of cordycepin via suppression of inflammatory mediators in BV2 microglial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Woo Jeong Research Topics

Disease

23Neoplasms (Cancer)
06/2022 - 12/2010
7Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 10/2015
6Mitochondrial Diseases (Mitochondrial Disease)
09/2022 - 06/2011
6Inflammation (Inflammations)
06/2021 - 09/2013
5Hepatocellular Carcinoma (Hepatoma)
04/2017 - 05/2013
4Leukemia
01/2021 - 06/2011
4Osteoarthritis
10/2017 - 12/2015
3Carcinoma (Carcinomatosis)
07/2017 - 05/2012
2Melanoma (Melanoma, Malignant)
07/2021 - 03/2017
2Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 05/2017
2Neoplasm Metastasis (Metastasis)
10/2018 - 10/2015
2Breast Neoplasms (Breast Cancer)
04/2018 - 01/2017
2Necrosis
10/2017 - 06/2011
2Chronic Disease (Chronic Diseases)
01/2017 - 01/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2013 - 12/2010
1Skin Diseases (Skin Disease)
09/2022
1Hyperpigmentation
07/2021
1Cardiotoxicity
07/2021
1Fatty Liver
06/2021
1Alcoholic Fatty Liver
06/2021
1Non-alcoholic Fatty Liver Disease
06/2021
1Body Weight (Weight, Body)
04/2021
1Dizziness (Lightheadedness)
01/2020
1Lung Neoplasms (Lung Cancer)
12/2019
1Transitional Cell Carcinoma
08/2019
1Bone Resorption
03/2019
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2019
1Carcinogenesis
10/2018
1Ataxia Telangiectasia (Louis Bar Syndrome)
02/2018
1Obesity
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2018
1Abscess
07/2015

Drug/Important Bio-Agent (IBA)

8Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022 - 06/2011
8cordycepinIBA
03/2020 - 12/2010
6Ethanol (Ethyl Alcohol)IBA
06/2022 - 01/2016
4AntioxidantsIBA
06/2021 - 10/2014
4Proteins (Proteins, Gene)FDA Link
09/2018 - 06/2011
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2018 - 05/2013
3Matrix Metalloproteinases (MMPs)IBA
06/2022 - 01/2017
3LigandsIBA
02/2018 - 09/2013
3CytokinesIBA
10/2017 - 12/2015
3CaspasesIBA
04/2017 - 06/2011
2loganinIBA
09/2022 - 01/2021
2LipopolysaccharidesIBA
01/2021 - 10/2018
2TriterpenesIBA
01/2021 - 10/2015
2FlavonoidsIBA
02/2018 - 03/2017
2Anthocyanins (Anthocyanin)IBA
01/2018 - 01/2013
2Cytochromes c (Cytochrome c)IBA
01/2018 - 01/2017
2InterleukinsIBA
10/2017 - 01/2017
2fucoidanIBA
05/2017 - 01/2017
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2017 - 03/2015
1Melanins (Melanin)IBA
07/2021
13-aminopropyl-cyclohexylmethylphosphinic acidIBA
07/2021
1Melanocyte-Stimulating Hormones (MSH)IBA
07/2021
1gamma-Aminobutyric Acid (GABA)IBA
07/2021
1BicucullineIBA
07/2021
1EnzymesIBA
06/2021
1ethyl acetateIBA
06/2021
1SilymarinIBA
06/2021
1Betulinic AcidIBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
03/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1honokiolIBA
01/2020
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2020
1Pharmaceutical PreparationsIBA
12/2019
1IsoflavonesIBA
08/2019
1GenisteinIBA
08/2019
1Adenosine Triphosphate (ATP)IBA
01/2019
1nargenicin A1IBA
01/2019
1Arsenic Trioxide (Trisenox)FDA Link
01/2019
1Tacrolimus (Prograf)FDA LinkGeneric
01/2019
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2018
1Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
10/2018
1Dinoprostone (PGE2)FDA Link
10/2018
1PolyaminesIBA
03/2018
1SpermidineIBA
03/2018
1Silybin (Lagosa)IBA
02/2018
1buteinIBA
02/2018
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2018
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
02/2018
1bufalinIBA
07/2017
1Thioredoxin-Disulfide ReductaseIBA
04/2017
1Auranofin (Ridaura)FDA Link
04/2017
1ClaudinsIBA
03/2017
1baicaleinIBA
03/2017
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2017
1Glutamine (L-Glutamine)FDA Link
01/2017
1Iodoacetic AcidIBA
01/2017
1Interleukin-1beta (Interleukin 1 beta)IBA
12/2015
1pachymic acidIBA
10/2015
1Biological ProductsIBA
10/2015
1Anti-Bacterial Agents (Antibiotics)IBA
07/2015
1Liposomes (Liposome)IBA
04/2015

Therapy/Procedure

3Therapeutics
06/2021 - 01/2017
2Traditional Medicine (Folk Remedies)
04/2018 - 01/2017
1Injections
06/2021
1Oral Administration
04/2021
1Catheters
07/2015